Talking about what others are afraid to say
Whether you watched the commercials or saw President Trump speak about this this past year, you know the spiel. TrumpRx.gov will offer the cheapest prescription drugs in the world starting …
Why “TrumpRx” Isn’t the Deal It’s Advertised to Be Read More
Pfizer currently has one of the weakest signals in oncology physician engagement. Pfizer spent $43 billion to acquire Seagen and transform itself into an oncology powerhouse—yet its oncology MSL organization …
Pfizer Spent $43 Billion to Become an Oncology Leader. So Why Do Its MSLs Rank Last With Oncologists? Read More
Recently released Aetna prior authorization data provide unprecedented transparency into the program’s inner workings. As frustrating as you might expect, the numbers also raise new questions about prior authorization’s impact …
Prior Authorization Isn’t Just Controlling Costs. It’s Making Denials Too Costly To Fight. Read More
Pharma marketers love the word “unbranded.” One benefit of an unbranded disease-awareness website is the ability to educate patients about a disease, help people understand symptoms, explain the impact of …
No, You Can’t Hide Promotion Inside “Unbranded” Disease Education Read More
PBMs have long justified their existence by arguing they keep prescription drug costs down by negotiating aggressively on behalf of plan sponsors with pharma manufacturers. The FTC’s July 20, 2024 …
PBMs Are Controlling The Market Read More
Last week, the Centers for Medicare & Medicaid Services decided to tighten up who qualifies as medically frail. Simply having cancer — even advanced, terminal cancer — may not automatically …
How Cruel Can American Healthcare Become? Read More
Washington loves to celebrate victories before the bill arrives. Medicare Part D was no exception. Biden’s IRA reformed Medicare drug benefits. Trump provided temporary subsidies to insurers so beneficiaries didn’t …
Why Medicare’s Drug Subsidy Is Ending Read More
Peptides are rapidly becoming one of the hottest trends in the health and wellness industry. What was once discussed only in research labs and the rare sports medicine clinic has …
Why Are Millions of Americans Taking Peptides? Read More